Latest National Institute of Allergy and Infectious Diseases Stories
PRINCETON, N.J., Dec. 29, 2014 /PRNewswire/ -- Soligenix, Inc.
A large team of American researchers has successfully completed the first step toward developing a vaccine for the Ebola virus.
Innovative research will support tools for the detection of potential bio-defense agents HUNTSVILLE, Ala., Dec.
ROCKVILLE, Md., Nov.
WASHINGTON, Nov. 5, 2014 /PRNewswire-USNewswire/ -- Following is a schedule of upcoming luncheons at the National Press Club.
BETHESDA, Md., Nov.
SUNNYVALE, Calif. and GENEVA, Switzerland, Oct.
Dr. Kottilil, formerly of the National Institute of Allergy & Infectious Diseases, becomes Co-Director of IHV's Clinical Research Unit BALTIMORE, Sept.
PRINCETON, N.J., Sept. 23, 2014 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., Sept. 19, 2014 /PRNewswire/ -- Soligenix, Inc.